Tetrylammonium

Tetrylammonium

SCHEMBL4772087

CC[N+](CC)(CC)CC.O=C(O)CC(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.56
SRR Q9GZT4 1/20 0.56
TSHR P16473 6/20 0.50
NFKB1 P19838 1/20 0.50
KCNA1 Q09470 1/20 0.50
KDM4E B2RXH2 1/20 0.47
PMP22 Q01453 1/20 0.47
ATM Q13315 1/20 0.47
FFAR3 O14843 2/20 0.44
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
ALDH1A1 P00352 4/20 0.35
LMNA P02545 1/20 0.35
APEX1 P27695 1/20 0.35
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 1/20 0.33
AKR1B1 P15121 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL27645685 0.84 FFAR3 (0.67) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL4772090 0.84 CA4 (0.43) LDHASRRTSHRNFKB1KCNA1
Tetrylammonium SCHEMBL168441 0.83 TSHR (0.61) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL29047701 0.83 TSHR (0.61) TSHRNFKB1KCNA1KDM4EPMP22
Malonic Acid SCHEMBL27693147 0.81 LDHA (0.56) LDHASRRTSHRATMFFAR3
Tetrylammonium SCHEMBL5874614 0.81 LMNA (0.56) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL36801 0.80 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL8111338 0.80 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Itaconate SCHEMBL5874665 0.80 ALOX15 (0.56) LDHASRRTSHRNFKB1KCNA1
Malonic Acid SCHEMBL28993583 0.79 LDHA (0.75) LDHASRRTSHRFFAR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878493-B1 Method of making a polyisocyanurate/polyurethane foam using carbocation compounds as trimerization catalysts AIR PROD & CHEM (US) 2013-08-21 EP claimed
US-8445555-B2 Stabilized carbanions as trimerization catalysts AIR PRODUCTS AND CHEMICALS, INC. (US) 2013-05-21 US claimed
US-20080015274-A1 Stabilized carbanions as trimerization catalysts EVONIK OPERATIONS GMBH (DE) 2008-01-17 US claimed
EP-1878493-A1 Stabilized carbanions as trimerization catalysts Air Products and Chemicals, Inc. (US) 2008-01-16 EP claimed
CN-101104149-A Stabilized carbanions as trimerization catalysts AIR PROD & CHEM (US) 2008-01-16 CN claimed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
EP-4700067-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPERSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-25 EP disclosed
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-12 US disclosed
EP-4692941-A2 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-02-11 EP disclosed
US-20260029706-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-01-29 US disclosed
EP-4621486-A2 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-18 US disclosed
EP-1878493-B1 Method of making a polyisocyanurate/polyurethane foam using carbocation compounds as trimerization catalysts AIR PROD & CHEM (US) 2013-08-21 EP disclosed
US-8445555-B2 Stabilized carbanions as trimerization catalysts AIR PRODUCTS AND CHEMICALS, INC. (US) 2013-05-21 US disclosed
CN-101104149-B Stabilized carbanions as trimerization catalysts AIR PROD & CHEM 2012-03-28 CN disclosed
US-20080015274-A1 Stabilized carbanions as trimerization catalysts EVONIK OPERATIONS GMBH (DE) 2008-01-17 US disclosed
EP-1878493-A1 Stabilized carbanions as trimerization catalysts Air Products and Chemicals, Inc. (US) 2008-01-16 EP disclosed
CN-101104149-A Stabilized carbanions as trimerization catalysts AIR PROD & CHEM (US) 2008-01-16 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS ASH2L, PUF60, IDUA LDHA 4123/4885SRR 287/4885TSHR 3217/4885
US-20260029706-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT SMC2, F12, SMC1A LDHA 3196/4885SRR 22/4885TSHR 3510/4885
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 LDHA 4837/4885SRR 3784/4885TSHR 770/4885
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SMC1A, SPOUT1, LBR LDHA 2343/4885SRR 37/4885TSHR 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.